Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | PPARG | P37231 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.31 |
| ▸ | NR2E3 | Q9Y5X4 | 1/20 | 0.31 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12412894 | 0.92 | — | — | |
| SCHEMBL12412920 | 0.88 | MAOB (0.32) | MAOBALDH1A1GAAHPGDKDM4E | |
| SCHEMBL12412990 | 0.86 | HTT (0.33) | MAOBALDH1A1GAAHPGDKDM4E | |
| SCHEMBL12412956 | 0.86 | HTT (0.36) | ALDH1A1GAAHPGDKDM4EHTT | |
| SCHEMBL12412847 | 0.85 | MAOB (0.32) | MAOBALDH1A1GAAHPGDKDM4E | |
| SCHEMBL12412838 | 0.85 | — | — | |
| SCHEMBL12413038 | 0.84 | ALDH1A1 (0.32) | ALDH1A1GAAHPGD | |
| SCHEMBL12412808 | 0.84 | ALDH1A1 (0.33) | MAOBALDH1A1GAAHPGDKDM4E | |
| SCHEMBL12412909 | 0.83 | — | — | |
| SCHEMBL12413012 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110166362-A1 | NOVEL COMPOUND AND ORGANIC SEMICONDUCTOR MATERIAL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110166362-A1 | NOVEL COMPOUND AND ORGANIC SEMICONDUCTOR MATERIAL | SCLY, MSRB3, SOD1 | MAOB 180/4885ALDH1A1 2760/4885GAA 4553/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.